Insulet Corp.
PODD
Hisse Senetlerindeki Sıralama
#2082
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Hisse Fiyatı
$143.87
Piyasa Değeri
$9.98B
Değişim (1 gün)
1.34%
Değişim (1 yıl)
-55.98%
Ülke
US
Ticaret Insulet Corp. (PODD)
Kategori
Healthcare
Insulet Corp. (PODD) için gelir
Jun 2026 itibarıyla gelir TTM: $3.05B
Insulet Corp. şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) $3.05B'dir. 2023 yılında şirketin geliri $1.70B önceki yıla göre artış 2022 yılındaki $1.31B gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
Insulet Corp. için 2002 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
| Yıl | Gelir | Değiştir |
|---|---|---|
| 2026 (TTM) | $3.05B | 47.40% |
| 2024 | $2.07B | 22.07% |
| 2023 | $1.70B | 30.02% |
| 2022 | $1.31B | 18.79% |
| 2021 | $1.10B | 21.49% |
| 2020 | $904.40M | 22.51% |
| 2019 | $738.20M | 30.93% |
| 2018 | $563.82M | 21.57% |
| 2017 | $463.77M | 26.37% |
| 2016 | $366.99M | 39.07% |
| 2015 | $263.89M | -8.60% |
| 2014 | $288.72M | 16.85% |
| 2013 | $247.08M | 16.90% |
| 2012 | $211.37M | 38.83% |
| 2011 | $152.26M | 57.02% |
| 2010 | $96.97M | 46.85% |
| 2009 | $66.03M | 83.12% |
| 2008 | $36.06M | 169.66% |
| 2007 | $13.37M | 265.06% |
| 2006 | $3.66M | 7,226.00% |
| 2005 | $50.00K | 0.00% |
| 2004 | 0.00 | 0.00% |
| 2003 | 0.00 | 0.00% |
| 2002 | 0.00 | 0.00% |
Benzer şirketler veya rakiplerin geliri
| Şirket | Gelir | Gelir Farkı | Ülke |
|---|---|---|---|
| $46.59B | 1,425.63% |
US
|
|
| $35.48B | 1,062.08% |
IE
|
|
| $25.84B | 746.14% |
US
|
|
| $21.00B | 587.60% |
US
|
|
| - | - |
DE
|
